GPC1 and familial pancreatic carcinoma: Similar theranostic approaches using small molecule inhibitors, peptides or nanoparticles targeting integrin αvβ6 [211], fibroblast activation protein [212,213], GPC1 [214] and IGF1 receptor [215] have also been investigated in mouse models of pancreatic cancer,